The objective of this review was to investigate the efficacy, effectiveness and safety of HPV vaccination in women undergoing conisation compared with those not receiving a HPV vaccination.
In 2023, significant increases in the number of measles cases and outbreaks were observed globally, including in 40 of the 53 countries of the European region, and in at least ten EU/EEA countries.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 16-22 July 2023 and includes updates on avian influenza, Echovirus 11, COVID-19, West Nile virus, poliomyelitis, and botulism.
This study provides insights for national public health authorities into the factors behind the spread of vaccine misinformation online and the options and capacities needed for responding to it.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 2-8 August 2020 and includes updates on the Ebola virus disease eleventh outbreak in the Democratic Republic of the Congo, Middle East respiratory syndrome coronavirus, poliomyelitis, West Nile virus, COVID-19 associated with SARS-CoV-2, monitoring environmental suitability of Vibrio growth in the Baltic Sea, influenza A(H3N2) variant virus – Hawaii, USA, tick-borne encephalitis in the UK, local transmission of dengue fever in France and babesiosis in the UK.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 28 June - 4 July 2020 and includes updates on COVID-19, Ebola virus disease, polio, vibrio, West Nile Virus and lyssavirus.
This document summarises evidence from studies included in the licensing file of HPV vaccines together with postlicensure, peer-reviewed data and analysis where available. This guidance does not address the safety of HPV vaccines observed during the pre- and post-licensing period.